The BIO CEO & Investor Conference

Fireside Chat with Jean-Jacques Bienaimé, CEO, BioMarin

Mr. Bienaimé joined BioMarin in May 2005 as chief executive officer and member of the board of directors, bringing with him over 25 years of experience in the biotechnology and pharmaceutical industries. Under his leadership, the market capitalization of BioMarin went from around $450 million in May 2005 to over $4.5 billion in the summer of 2012. BioMarin 2012 revenues are anticipated to be approximately $500 million. BioMarin is a fully integrated biopharmaceutical company with over 1000 employees.

Tales From the Wild West (Wing): Reflections from White House Chiefs of Staff

The election chips have fallen and the country is gearing up for another four years of economic challenges and political wrangling. With divided government, compromises will be difficult and time consuming to reach, but will be necessary to deal with big issues the U.S. faces.

Glad to join Josh Bolten at #BIOCEO13 to talk tax policy, health reform, & prepping the #sotu with Presidents Clinton & Bush cc @iambiotech

— John Podesta (@johnpodesta) February 12, 2013